246 related articles for article (PubMed ID: 25541214)
21. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
Portnoy A; Jit M; Helleringer S; Verguet S
Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
[TBL] [Abstract][Full Text] [Related]
22. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
23. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
[TBL] [Abstract][Full Text] [Related]
24. Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016.
Oh DH; Dabbagh A; Goodson JL; Strebel PM; Thapa S; Giri JN; Shakya SR; Khanal S
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(39):1072-1076. PubMed ID: 27711034
[TBL] [Abstract][Full Text] [Related]
25. Targeting Adults for Supplementary Immunization Activities of Measles Control in Central China: A Mathematical Modelling Study.
Chong KC; Zhang C; Jia KM; Zee BCY; Luo T; Wang L; Tam GCH; Sun R; Wang MH; Guan X
Sci Rep; 2018 Oct; 8(1):16124. PubMed ID: 30382120
[TBL] [Abstract][Full Text] [Related]
26. Progress in measles control--Zambia, 1999-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):581-4. PubMed ID: 15959454
[TBL] [Abstract][Full Text] [Related]
27. A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.
Clements CJ; Soakai TS; Sadr-Azodi N
Expert Rev Vaccines; 2017 Feb; 16(2):161-174. PubMed ID: 27690704
[TBL] [Abstract][Full Text] [Related]
28. The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
Chakrabarti A; Grépin KA; Helleringer S
PLoS One; 2019; 14(2):e0212049. PubMed ID: 30763389
[TBL] [Abstract][Full Text] [Related]
29. Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
Orenstein WA; Hinman A; Nkowane B; Olive JM; Reingold A
Vaccine; 2018 Jan; 36 Suppl 1():A1-A34. PubMed ID: 29307367
[TBL] [Abstract][Full Text] [Related]
30. Progress in measles control--Kenya 2002-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
[TBL] [Abstract][Full Text] [Related]
31. Progress in measles mortality reduction in Ethiopia, 2002-2009.
Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
[TBL] [Abstract][Full Text] [Related]
32. Progress toward measles and rubella elimination in Egypt.
El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
[TBL] [Abstract][Full Text] [Related]
33. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
Elife; 2021 Jun; 10():. PubMed ID: 34165077
[TBL] [Abstract][Full Text] [Related]
34. Measles-rubella mass immunization campaign in Albania, November 2000.
Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.
Thompson KM; Odahowski CL; Goodson JL; Reef SE; Perry RT
Risk Anal; 2016 Jul; 36(7):1427-58. PubMed ID: 26249328
[TBL] [Abstract][Full Text] [Related]
36. Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges.
Johri M; Sharma JK; Jit M; Verguet S
Vaccine; 2013 Feb; 31(9):1259-63. PubMed ID: 23041086
[TBL] [Abstract][Full Text] [Related]
37. Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.
Gurnani V; Haldar P; Khanal S; Bhatnagar P; Singh B; Ahmed D; Samiuddin M; Kumar A; Negi Y; Gupta S; Harvey P; Bahl S; Dabbagh A; Alexander JP; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(26):742-746. PubMed ID: 29975677
[TBL] [Abstract][Full Text] [Related]
38. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
[TBL] [Abstract][Full Text] [Related]
39. The unfinished measles immunization agenda.
Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
[TBL] [Abstract][Full Text] [Related]
40. Progress toward measles elimination--European Region, 2005--2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
